• The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Professor Michael Millward is the foundation Chair of Clinical Cancer Research, University of Western Australia, Consultant Medical Oncologist at Linear Clinical Research, and Adjunct Professor, School of Medical and Health Sciences, Edith Cowan University. He has a strong track record in delivering clinical trial outcomes, particularly with novel therapeutics and phase I studies. He is an international expert on the management of thoracic malignancies and melanoma and has conducted many clinical trials in these areas. Michael Millward has collaborated extensively with the ECU team to develop liquid biomarkers (CTCs, ctDNA) for melanoma. He has also collaborated extensively with PathWest to develop and implement molecular tumour testing and currently he is currently the WA lead for the MoST pan-cancer and the ASPiRATION lung cancer trials which is expanding molecular testing testing nationwide. He was the President of the Australasian Lung Cancer Trials Group (now Thoracic Oncology Group Australasia) until August 2012. In 2017 Professor Millward was elected as a Fellow of Edith Cowan University for his clinical and translational work on melanoma and received the Cancer Council WA Career Achievement Award.


I have an active and productive record of research in various clinical and pharmacology aspects of anti-cancer treatments. The theme has been to develop and introduce promising new agents into clinical research in Australia, and optimise and further develop the potential of existing treatment modalities. My current strategic focus is to enhance Western Australia as a centre for research excellence by developing networks with other research groups and institutions, both within and outside the QEII precinct.



Editorial work

  • On the editorial board of Investigational New Drugs since 2002

Service and Engagement

  • Setting up of monthly cancer education meetings for Oncologists and advanced trainees in Perth (commenced 2005) and attracted approx. $15,000 per annum sponsorship from Industry to run these meetings with no restriction on topics or speakers.
  • Joining a committee involved in organising the 2013 World Lung Cancer Conference in Sydney.  This was the largest Medical Conference held to date in Australia and received a NSW State Award as the most outstanding conference held in 2013

Previous positions

December 1978-January 1979: Vacation Research Scholar in the Pathology Department of the King Edward Memorial Hospital for Women, Perth WA.

January 1982-December 1985: Intern, RMO, and Registrar, Sir Charles Gairdner Hospital, Perth, WA.

January 1986-July 1988: Medical Oncology Advanced Trainee (Registrar), Sir Charles Gairdner Hospital & Royal Perth Hospitals, Perth, WA.

September 1988-January 1989: Clinical Research Associate & Honorary Registrar, University Department of Clinical Oncology, Newcastle General Hospital, University of Newcastle Upon Tyne, UK.

January 1989-May 1992: Clinical Research Fellow & Honorary Senior Registrar, University Department of Clinical Oncology, Newcastle General Hospital, University of Newcastle Upon Tyne and Cancer Research Unit, University of Newcastle Upon Tyne, UK.

June 1992-July 1998: Consultant Medical Oncologist, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne.

October 1994-Jan 1995: Locum Director of Oncology, Box Hill Hospital, Melbourne.

May 1997-July 1998: Consultant Medical Oncologist (Honorary), St Vincent’s Hospital, Melbourne.

January 1998 - July 1998: Clinical Associate Professor, Department of Medicine, St Vincent’s & Geelong Hospitals, University of Melbourne

August 1998 - June 2003: Senior Staff Specialist, Central Sydney Area Health Service (Royal Prince Alfred & Concord Hospitals).

August 1998 - June 2003: Head of Clinical Research, Sydney Cancer Centre.

July 2002 - June 2003: Clinical Associate Professor, University of Sydney.

April 2004 - April 2006: Head of Unit, School of Medicine and Pharmacology, Sir Charles Gairdner Hospital (completed April 2006, Acting Head of Unit Dec 06-Feb 07).

February 2005-December 2006: Chairman, Western Australian Clinical Oncology Group.

June 2007 - November 2008 , June 2013 - June 2015: Chairman, Cancer Therapeutics Research Group

August 2008 – August 2012: President, Australasian Lung Cancer Trials Group

November 2007 – November 2013: Head of Department, Medical Oncology, Sir Charles Gairdner Hospital

July 2005 – December 2018: Director, Cancer Trials WA

August 2003 – December 2020: Consultant Medical Oncologist, Sir Charles Gairdner Hospital (SCGH), North Metropolitan Health Service, Western Australia

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 14 - Life Below Water

Education/Academic qualification

MA (Bioethics), Clinical trials of new cancer treatments: Do they exploit patients?, Monash University (Australia)

… → 1996

MBBS, The University of Western Australia

… → 1982

External positions

Director of Cancer Trials, Linear Clinical Research

2021 → …

Adjunct Professor, Edith Cowan University

2020 → …

Honorary Associate, University of Sydney

2009 → …

Research expertise keywords

  • Cancer
  • Clinical trials


Dive into the research topics where Michael Millward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or